Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_assertion type Assertion NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_head.
- NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_assertion description "[We examined the effects of the mammalian target of rapamycin inhibitor, rapamycin, on mammary tumorigenesis in transgenic mice bearing an activated ErbB2 (NeuYD) transgene in the absence or presence of a second transgene encoding vascular endothelial growth factor (VEGF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_provenance.
- NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_assertion evidence source_evidence_literature NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_provenance.
- NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_assertion SIO_000772 15958580 NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_provenance.
- NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_assertion wasDerivedFrom befree-2016 NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_provenance.
- NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_assertion wasGeneratedBy ECO_0000203 NP499733.RAYCxMte8tWYM0q-7s2_3CDU-G4z8v5rgG4ucM8Itp7KM130_provenance.